安耐森 ANNX
$4.20 +$0.20 (+4.87%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $4.20 0.00%
开盘$4.05
昨收$4.01
当日区间$4.03 – $4.29
成交量2.62M
市值$796.23M
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例102.8%-7.02 个百分点，较上季度
持仓机构数255+1 ，较上季度
内部人近期交易34次买入 / 16次卖出净买入
空头持仓比例16.68% 占流通股回补天数 10.3 · 截至 15 Oct 2026
卖空成交量占比18.4%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$2.23M（6个净流入日，14个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有35.3%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从18.78%降至16.68%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Redmile Group, LLC | Hedge Fund | 2026/Q3 | +2,679,019 | 7.7% |
| FMR | Mutual Fund | 2026/Q3 | +8,881,850 | 10.3% |
| Woodline Partners LP | Hedge Fund | 2026/Q3 | +4,587,930 | 3.7% |
| MPM BioImpact LLC | VC/PE Fund | 2026/Q3 | +3,544,354 | 1.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +2,905,066 | 5.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +2,601,235 | 7.1% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +1,912,568 | 1.7% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +1,760,131 | 1.4% |
| Logos Global Management, L.P. | Hedge Fund | 2026/Q3 | +1,500,000 | 0.8% |
| Candriam, Société En Commandite Par Actions | Mutual Fund | 2026/Q3 | +1,195,142 | 0.6% |
| MAK Capital One, LLC | Hedge Fund | 2026/Q3 | +1,138,137 | 3.1% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +1,131,324 | 4.2% |
| Foord Asset Management Guernsey Ltd | Mutual Fund | 2026/Q3 | +1,000,889 | 0.5% |
| Great Point Partners, LLC | VC/PE Fund | 2026/Q3 | +1,000,000 | 1.8% |
| PanAgora Asset Management, Inc. | Mutual Fund | 2026/Q3 | +967,926 | 0.5% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 23 Sep 2026 | Douglas Love | Chief Executive Officer | Open Market Acquisition | +26,065 | $3.83 | 390,476 |
| 12 Aug 2026 | Thomas Wiggans | Former Independent Chairperson | Intent to Sell (Form 144) | -2,000 | $5.30 | – |
| 9 Aug 2026 | Mark Blumenkranz | Director | Other Derivative Acquisition | +175,000 | $5.39 | 175,000 |
| 14 Jul 2026 | Thomas Wiggans | Former Independent Chairperson | Intent to Sell (Form 144) | -2,000 | $6.32 | – |
| 13 Jul 2026 | Thomas Wiggans | Former Independent Chairperson | Intent to Sell (Form 144) | -1,000 | $5.61 | – |
| 10 Jun 2026 | Muneer Satter | Former Independent Director | Other Derivative Acquisition | +65,000 | $4.70 | 65,000 |
| 10 Jun 2026 | Jung Choi | Independent Director | Other Derivative Acquisition | +65,000 | $4.70 | 65,000 |
| 10 Jun 2026 | William Waddill | Interim Lead Independent Director | Other Derivative Acquisition | +65,000 | $4.70 | 65,000 |
| 10 Jun 2026 | Ted Yednock | Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board | Derivative Exercise and Retained | +30,646 | $1.85 | 184,807 |
| 10 Jun 2026 | William Jones | Independent Director | Other Derivative Acquisition | +65,000 | $4.70 | 65,000 |
| 10 Jun 2026 | William Carson | Independent Director | Other Derivative Acquisition | +65,000 | $4.70 | 65,000 |
| 10 Jun 2026 | Bettina Cockroft | Independent Director | Other Derivative Acquisition | +65,000 | $4.70 | 65,000 |
| 27 May 2026 | Alerce Investment Management L.P. | Open Market Acquisition | +613,497 | $5.41 | 9,534,894 | |
| 10 May 2026 | William Carson | Independent Director | Automatic Acquisition | +8,000 | $5.78 | 78,405 |
| 9 Apr 2026 | William Carson | Independent Director | Automatic Acquisition | +8,000 | $6.20 | 70,405 |
| 9 Mar 2026 | William Carson | Independent Director | Automatic Acquisition | +8,000 | $5.67 | 62,405 |
| 1 Mar 2026 | Dean Artis | Chief Scientific Officer & Executive VP | Open Market Disposition | -5,894 | $5.43 | 74,618 |
| 1 Mar 2026 | Ted Yednock | Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board | Open Market Disposition | -5,566 | $5.42 | 154,161 |
| 1 Mar 2026 | Jennifer Lew | Chief Financial Officer | Open Market Disposition | -5,565 | $5.42 | 65,225 |
| 1 Mar 2026 | Jamie Dananberg | Chief Medical Officer | Open Market Disposition | -5,820 | $5.43 | 24,357 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 31,627,401 | 16.7% | 10.3 |
| 30 Sep 2026 | 32,009,914 | 16.9% | 8.9 |
| 15 Sep 2026 | 32,871,995 | 17.3% | 11.7 |
| 31 Aug 2026 | 32,094,286 | 16.9% | 12.7 |
| 14 Aug 2026 | 32,583,299 | 17.2% | 13.2 |
| 31 Jul 2026 | 30,772,146 | 18.8% | 10.5 |
暂无评论——快来第一个聊聊 ANNX。
登录后参与讨论。